Section 1.1: Enhancing Embryo Selection

Life Whisperer Genetics employs artificial intelligence and machine learning to assist embryologists during the embryo selection process. Traditionally, embryologists rely on subjective criteria through a method known as embryo morphology grading.

Life Whisperer's AI technology enhances this process by recognizing features that are not visible to the human eye, thereby incorporating objective measures that elevate the likelihood of successful implantation. Research indicates that AI-driven embryo selection is at least 25% more precise than conventional grading methods used by embryologists when predicting pregnancy success.

The AI model's distribution of viability ratings effectively differentiates between viable and non-viable embryos, demonstrating its capabilities.

Artificial intelligence complements, rather than replaces, the vital role of embryologists. It augments their ability to choose optimal candidates by providing an additional layer of objective assessment. Life Whisperer Genetics has analyzed over 20,000 two-dimensional embryo images from various global sources, each with established pregnancy outcomes, to develop its AI system. As the system processes more data, its predictive capabilities continue to improve.

Section 1.2: Reducing the Need for Genetic Testing

Furthermore, Life Whisperer Genetics' technology can minimize the necessity for preimplantation genetic testing (PGT-A). Genetically healthy embryos generally have higher implantation rates and lower miscarriage risks. Some couples opt for preimplantation testing, which involves the biopsy of embryos for genetic evaluation. This process, while informative, incurs additional costs and carries slight risks.

According to CEO Dr. Michelle Perugini, their innovative solution effectively addresses these issues. She stated, “Essentially without biopsying an embryo, we can assess the likelihood of it being genetically normal or genetically abnormal just through using artificial intelligence and the images of the embryos.”

Life Whisperer Genetics evaluates embryos' genetic integrity through digital camera imagery. In studies, the AI successfully identified normal embryos in 82% of simulations involving 91,500 patients. The cloud-based assessment provides IVF couples with straightforward and accessible reports that enhance their understanding of the IVF process.

Currently, this technology has not received FDA approval for application in the United States. However, according to the company's website, Life Whisperer Genetics is approved for use in the UK, Europe, Australia, New Zealand, Canada, India, Japan, Hong Kong, Singapore, and Vietnam. This technology offers assistance to patients in regions where preimplantation testing is either unavailable or prohibitively expensive.

In the United States, preimplantation genetic testing is commonplace, but its high costs often dissuade potential patients from pursuing IVF. The integration of AI could significantly reduce expenses, thereby making assisted reproductive technologies more accessible to individuals seeking to expand their families.

Life Whisperer Genetics is currently pursuing approvals in Europe, Australia, Canada, India, and Southeast Asia, with expectations for approval in May. The company is also seeking FDA approval in the U.S.

To delve deeper into how artificial intelligence can enhance IVF outcomes, watch the following video.